Lowenstein Sandler represented Applied Digital Corporation in the transaction. Applied Digital Corporation completed a committed equity facility of up to $250 million with YA II PN,...
Applied Digital’s $250 Million Committed Equity Facility
Applied Digital’s $53.2 Million Convertible Preferred Stock Issuance
Lowenstein represented Applied Digital in the transaction. Applied Digital completed a private financing arrangement with a single investor pursuant to which the company issued $53.2 million...
Applied Digital’s $160 Million Private Placement Financing
Lowenstein Sandler represented Applied Digital Corporation on the transaction. Applied Digital signed definitive agreements for a $160 million private placement financing, priced at market, from a...
Applied Digital’s Private Debt Facility to Accelerate North Dakota Data Center Project
Lowenstein Sandler represented Applied Digital Corporation in the transaction. Applied Digital Corporation (NASDAQ: APLD) announced the closing of a $125 million loan to fund the company’s...
Riddell’s Partnership with BC Partners Credit
Lowenstein Sandler represented Riddell, Inc. in the transaction. Riddell, Inc., the industry leader in football helmet technology and sports protection innovation, announced the formation of a...
ZMC’s Acquisition of InProduction
Willkie Farr & Gallagher LLP acted as legal advisor to InProduction, Lowenstein Sandler LLP acted as legal advisor to ZMC, while Latham & Watkins LLP represented...
Phreesia’s Acquisition of Access eForms
Lowenstein Sandler represented Phreesia in the transaction. Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, announced the acquisition of Access eForms, an...
Blackstone’s Acquisition of Majority Stake in New Tradition Holdings
Lowenstein represented New Tradition Holdings LLC in the transaction. New Tradition Holdings LLC, a leading out-of-home media operator with assets across the nation’s largest markets, announced its...
Tonix Pharmaceuticals’ Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio
Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) signed an agreement to acquire assets of Healion Bio, Inc., including its...